Exposure Levels of Anti-LINGO-1 Li81 Antibody in the Central Nervous System and Dose-Efficacy Relationships in Rat Spinal Cord Remyelination Models after Systemic Administration-Reference-Cited by-同舟云学术

Exposure Levels of Anti-LINGO-1 Li81 Antibody in the Central Nervous System and Dose-Efficacy Relationships in Rat Spinal Cord Remyelination Models after Systemic Administration

Published:2011-08-01 Issue:2 Volume:339 Page:519-529
ISSN:0022-3565
Container-title:Journal of Pharmacology and Experimental Therapeutics
language:en
Short-container-title:J Pharmacol Exp Ther

Author:

Pepinsky R. Blake,Shao Zhaohui,Ji Benxiu,Wang Qin,Meng Gym,Walus Lee,Lee Xinhua,Hu Yinghui,Graff Christilyn,Garber Ellen,Meier Werner,Mi Sha

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference30 articles.

1. The blood-brain barrier transmigrating single domain antibody: mechanisms of transport and antigenic epitopes in human brain endothelial cells

2. Recombinant Antibodies as Therapeutic Agents

3. Pharmacokinetics of IgG and IgM anti-ganglioside antibodies in rats and monkeys after intrathecal administration;Bergman;J Pharmacol Exp Ther,1998

4. Selective targeting of a TNFR decoy receptor pharmaceutical to the primate brain as a receptor-specific IgG fusion protein

5. A 4-Week Intrathecal Toxicity and Pharmacokinetic Study With Trastuzumab in Cynomolgus Monkeys

Cited by 82 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Application of In vitro transcytosis models to brain targeted biologics;PLOS ONE;2023-08-23

2. Anti-LINGO-1 antibody protects neurons and synapses in the medial prefrontal cortex of APP/PS1 transgenic mice;Neuroscience Research;2023-08

3. Mechanisms of Demyelination and Remyelination Strategies for Multiple Sclerosis;International Journal of Molecular Sciences;2023-03-28

4. Nogo receptor-Fc delivered by haematopoietic cells enhances neurorepair in a multiple sclerosis model;Brain Communications;2023-03-02

5. Immunomodulation;Prions and Diseases;2023